| pubmed-article:8571910 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8571910 | lifeskim:mentions | umls-concept:C1801960 | lld:lifeskim |
| pubmed-article:8571910 | lifeskim:mentions | umls-concept:C0246249 | lld:lifeskim |
| pubmed-article:8571910 | lifeskim:mentions | umls-concept:C1979874 | lld:lifeskim |
| pubmed-article:8571910 | lifeskim:mentions | umls-concept:C0520510 | lld:lifeskim |
| pubmed-article:8571910 | lifeskim:mentions | umls-concept:C1522609 | lld:lifeskim |
| pubmed-article:8571910 | lifeskim:mentions | umls-concept:C1554112 | lld:lifeskim |
| pubmed-article:8571910 | lifeskim:mentions | umls-concept:C2349975 | lld:lifeskim |
| pubmed-article:8571910 | lifeskim:mentions | umls-concept:C2827155 | lld:lifeskim |
| pubmed-article:8571910 | lifeskim:mentions | umls-concept:C1627358 | lld:lifeskim |
| pubmed-article:8571910 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:8571910 | pubmed:dateCreated | 1996-3-1 | lld:pubmed |
| pubmed-article:8571910 | pubmed:abstractText | The purpose of this study were to quantify abdominal vascular enhancement and to prove the feasibility of iron oxide-enhanced MR angiography in humans using three doses of superparamagnetic iron oxide agent AMI 227. | lld:pubmed |
| pubmed-article:8571910 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8571910 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8571910 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8571910 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:8571910 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8571910 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8571910 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8571910 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8571910 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8571910 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8571910 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8571910 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8571910 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:8571910 | pubmed:issn | 0361-803X | lld:pubmed |
| pubmed-article:8571910 | pubmed:author | pubmed-author:SharmaPP | lld:pubmed |
| pubmed-article:8571910 | pubmed:author | pubmed-author:SlaterGG | lld:pubmed |
| pubmed-article:8571910 | pubmed:author | pubmed-author:KaufmanJ AJA | lld:pubmed |
| pubmed-article:8571910 | pubmed:author | pubmed-author:SainoYY | lld:pubmed |
| pubmed-article:8571910 | pubmed:author | pubmed-author:HahnP FPF | lld:pubmed |
| pubmed-article:8571910 | pubmed:author | pubmed-author:Mayo-SmithW... | lld:pubmed |
| pubmed-article:8571910 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8571910 | pubmed:volume | 166 | lld:pubmed |
| pubmed-article:8571910 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8571910 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8571910 | pubmed:pagination | 73-7 | lld:pubmed |
| pubmed-article:8571910 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:8571910 | pubmed:meshHeading | pubmed-meshheading:8571910-... | lld:pubmed |
| pubmed-article:8571910 | pubmed:meshHeading | pubmed-meshheading:8571910-... | lld:pubmed |
| pubmed-article:8571910 | pubmed:meshHeading | pubmed-meshheading:8571910-... | lld:pubmed |
| pubmed-article:8571910 | pubmed:meshHeading | pubmed-meshheading:8571910-... | lld:pubmed |
| pubmed-article:8571910 | pubmed:meshHeading | pubmed-meshheading:8571910-... | lld:pubmed |
| pubmed-article:8571910 | pubmed:meshHeading | pubmed-meshheading:8571910-... | lld:pubmed |
| pubmed-article:8571910 | pubmed:meshHeading | pubmed-meshheading:8571910-... | lld:pubmed |
| pubmed-article:8571910 | pubmed:meshHeading | pubmed-meshheading:8571910-... | lld:pubmed |
| pubmed-article:8571910 | pubmed:meshHeading | pubmed-meshheading:8571910-... | lld:pubmed |
| pubmed-article:8571910 | pubmed:meshHeading | pubmed-meshheading:8571910-... | lld:pubmed |
| pubmed-article:8571910 | pubmed:meshHeading | pubmed-meshheading:8571910-... | lld:pubmed |
| pubmed-article:8571910 | pubmed:meshHeading | pubmed-meshheading:8571910-... | lld:pubmed |
| pubmed-article:8571910 | pubmed:meshHeading | pubmed-meshheading:8571910-... | lld:pubmed |
| pubmed-article:8571910 | pubmed:meshHeading | pubmed-meshheading:8571910-... | lld:pubmed |
| pubmed-article:8571910 | pubmed:meshHeading | pubmed-meshheading:8571910-... | lld:pubmed |
| pubmed-article:8571910 | pubmed:meshHeading | pubmed-meshheading:8571910-... | lld:pubmed |
| pubmed-article:8571910 | pubmed:meshHeading | pubmed-meshheading:8571910-... | lld:pubmed |
| pubmed-article:8571910 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:8571910 | pubmed:articleTitle | MR contrast material for vascular enhancement: value of superparamagnetic iron oxide. | lld:pubmed |
| pubmed-article:8571910 | pubmed:affiliation | Department of Radiology, Massachusetts General Hospital, Boston 02114, USA. | lld:pubmed |
| pubmed-article:8571910 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8571910 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:8571910 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:8571910 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:8571910 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8571910 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8571910 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8571910 | lld:pubmed |
